Trial alert-Reference-Cited by-同舟云学术

Trial alert

Published:1989-11 Issue:6 Volume:3 Page:795-796
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drug Ther

Author:

Opie Lionel

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01869562.pdf

Reference7 articles.

1. DiBianco R, Shabetai R, Kostuk W, et al. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.N Engl J Med 1989;320:677–683.

2. The CAST Investigators: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med 1989;321:406–412.

3. Lichtlen PR, Nellessen U, Rafflenbeul W, et al. International nifedipine trial on antiatherosclerotic therapy (INTACT).Cardiovasc Drugs Ther 1987; 1:71–79.

4. Kober G, Schneider W, Kaltenbach M. Can the progression of coronary sclerosis be influenced by calcium antagonists?J Cardiovasc Pharmacol 1989;13 Suppl 4:S2-S6.

5. German-Austrian Xamoterol Study. Double-blind placebocontrolled comparison of digoxin and xamoterol in chronic heart failure.Lancet 1988;1:489–493.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of Metabolite Profile of YM758, a Novel If Channel Inhibitor;Drugs in R&D;2016-03-30

2. Identification of Human Metabolites of (–)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a Novel If Channel Inhibitor, and Investigation of the Transporter-Mediated Renal and Hepatic Excretion of These Metabolites;Drug Metabolism and Disposition;2009-05-13

3. Comparative evaluation of absorption, distribution, and excretion of YM758, a novel If channel inhibitor, between albino and non-albino rats;Xenobiotica;2008-05

4. Hepatic Uptake and Excretion of (–)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a Novel If Channel Inhibitor, in Rats and Humans;Drug Metabolism and Disposition;2008-03-10